490 related articles for article (PubMed ID: 30541321)
21. Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS.
Arriola E; Paredes-Lario A; García-Gomez R; Diz-Tain P; Constenla M; García-Girón C; Márquez G; Reck M; López-Vivanco G
Clin Transl Oncol; 2018 Oct; 20(10):1261-1267. PubMed ID: 29623586
[TBL] [Abstract][Full Text] [Related]
22. A Comparative Study for Detection of
Kim Y; Shin S; Lee KA
Biomed Res Int; 2018; 2018():7392419. PubMed ID: 29854785
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation.
Cho MS; Park CH; Lee S; Park HS
PLoS One; 2020; 15(3):e0230622. PubMed ID: 32196518
[TBL] [Abstract][Full Text] [Related]
24. Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.
Li Y; Xu H; Su S; Ye J; Chen J; Jin X; Lin Q; Zhang D; Ye C; Chen C
PLoS One; 2017; 12(8):e0183331. PubMed ID: 28829813
[TBL] [Abstract][Full Text] [Related]
25. Afatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with Rare EGFR (in exon 18-T179X) Mutation - a Case Report.
Čoupková H; Vyzula R
Klin Onkol; 2018; 31(5):380-383. PubMed ID: 30541326
[TBL] [Abstract][Full Text] [Related]
26. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
27. Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer.
Normanno N; Denis MG; Thress KS; Ratcliffe M; Reck M
Oncotarget; 2017 Feb; 8(7):12501-12516. PubMed ID: 27980215
[TBL] [Abstract][Full Text] [Related]
28. Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer.
Jenkins S; Yang JC; Ramalingam SS; Yu K; Patel S; Weston S; Hodge R; Cantarini M; Jänne PA; Mitsudomi T; Goss GD
J Thorac Oncol; 2017 Jul; 12(7):1061-1070. PubMed ID: 28428148
[TBL] [Abstract][Full Text] [Related]
29. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.
van der Leest P; Rozendal P; Hinrichs J; van Noesel CJM; Zwaenepoel K; Deiman B; Huijsmans CJJ; van Eijk R; Speel EJM; van Haastert RJ; Ligtenberg MJL; van Schaik RHN; Jansen MPHM; Dubbink HJ; de Leng WW; Leers MPG; Tamminga M; van den Broek D; van Kempen LC; Schuuring E
Clin Chem; 2024 May; 70(5):759-767. PubMed ID: 38484302
[TBL] [Abstract][Full Text] [Related]
30. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.
Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y
Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405
[TBL] [Abstract][Full Text] [Related]
31. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
Yang X; Zhuo M; Ye X; Bai H; Wang Z; Sun Y; Zhao J; An T; Duan J; Wu M; Wang J
Oncotarget; 2016 Apr; 7(15):20810-24. PubMed ID: 26989078
[TBL] [Abstract][Full Text] [Related]
32. Detection of epidermal growth factor receptor (
Guo K; Shao C; Han L; Liu H; Ma Z; Yang Y; Feng Y; Pan M; Santarpia M; Carmo-Fonseca M; Silveira C; Lee KY; Han J; Li X; Yan X
Transl Lung Cancer Res; 2021 Jul; 10(7):3213-3225. PubMed ID: 34430359
[TBL] [Abstract][Full Text] [Related]
33. Performance comparison of commercial kits for isolating and detecting circulating tumor DNA.
Wang M; Huang X; Li X; Guo Q; Xu W; Zhao M; Wang X; Wang L; Lou J
Scand J Clin Lab Invest; 2021 Jul; 81(4):276-281. PubMed ID: 33999736
[TBL] [Abstract][Full Text] [Related]
34. Real-World Data of the Correlation between EGFR Determination by Liquid Biopsy in Non-squamous Non-small Cell Lung Cancer (NSCLC) and the EGFR Profile in Tumor Biopsy.
Soria-Comes T; Palomar-Abril V; Ureste MM; Guerola MT; Maiques ICM
Pathol Oncol Res; 2020 Apr; 26(2):845-851. PubMed ID: 30847713
[TBL] [Abstract][Full Text] [Related]
35. Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations.
Poole JC; Wu SF; Lu TT; Vibat CRT; Pham A; Samuelsz E; Patel M; Chen J; Daher T; Singh VM; Arnold LJ
PLoS One; 2019; 14(10):e0223112. PubMed ID: 31581267
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer.
Wan R; Wang Z; Lee JJ; Wang S; Li Q; Tang F; Wang J; Sun Y; Bai H; Wang D; Zhao J; Duan J; Zhuo M; An T; Wu M; Chen Z; Yang Z; Wang J
J Thorac Oncol; 2017 Sep; 12(9):1376-1387. PubMed ID: 28552765
[TBL] [Abstract][Full Text] [Related]
37. The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study.
Ding PN; Becker TM; Bray VJ; Chua W; Ma YF; Lynch D; Po J; Luk AWS; Caixeiro N; de Souza P; Roberts TL
Lung Cancer; 2019 Aug; 134():187-193. PubMed ID: 31319980
[TBL] [Abstract][Full Text] [Related]
38. ctDNA from body fluids is an adequate source for
Pérez-Barrios C; Sánchez-Herrero E; Garcia-Simón N; Barquín M; Clemente MB; Provencio M; Romero A
Clin Chem Lab Med; 2021 Jun; 59(7):1221-1229. PubMed ID: 33691348
[TBL] [Abstract][Full Text] [Related]
39. Exosome-Based Detection of
Castellanos-Rizaldos E; Grimm DG; Tadigotla V; Hurley J; Healy J; Neal PL; Sher M; Venkatesan R; Karlovich C; Raponi M; Krug A; Noerholm M; Tannous J; Tannous BA; Raez LE; Skog JK
Clin Cancer Res; 2018 Jun; 24(12):2944-2950. PubMed ID: 29535126
[No Abstract] [Full Text] [Related]
40. Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer.
Imamura F; Uchida J; Kukita Y; Kumagai T; Nishino K; Inoue T; Kimura M; Oba S; Kato K
Lung Cancer; 2016 Apr; 94():68-73. PubMed ID: 26973209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]